Is screening for colorectal cancer worthwhile?
Author Information
Author(s): J. Chamberlain
Primary Institution: Institute of Cancer Research
Hypothesis
Is screening for colorectal cancer effective in reducing incidence and mortality?
Conclusion
Screening for colorectal cancer is feasible but its effectiveness in reducing mortality and incidence is still uncertain.
Supporting Evidence
- Colorectal cancer is the third commonest cause of death from malignant disease in the UK.
- Screening can detect precancerous adenomas and early invasive carcinomas.
- Survival rates for stage A tumors are over 80%, but less than 10% of patients present at this stage.
Takeaway
Screening for colorectal cancer can help find and remove early signs of cancer, but we still don't know if it actually saves lives.
Methodology
The text reviews various screening methods and their effectiveness based on existing studies.
Potential Biases
The studies reviewed may have biases due to self-selection of participants and small sample sizes.
Limitations
There is insufficient knowledge about the duration of the pre-invasive phase and the effectiveness of screening in reducing mortality.
Participant Demographics
The majority of colorectal cancer cases occur in individuals over 50 years old.
Want to read the original?
Access the complete publication on the publisher's website